Acurx Pharmaceuticals (ACXP) Misses Q4 EPS by 12c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.37), $0.12 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet slides over 6% as AI brain drain and SpaceX slump converge
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits